📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Orthogonal engineering of synthetic T cell states to enhance cancer immunotherapy. (2023)

First Author: Conti AG

Attributed to: Understanding and targeting the suppressive function of the ARHGEF1 pathway to unleash T cell immunity against cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41590-023-01470-9

PubMed Identifier: 37081149

Publication URI: http://europepmc.org/abstract/MED/37081149

Type: Journal Article/Review

Volume: 24

Parent Publication: Nature immunology

Issue: 5

ISSN: 1529-2908